Who Joined Us in 2025?
Here's a small sample of attendees from the Commercialization Community:
Senior Vice President, Worldwide Commercial Portfolio Strategy, Bristol Myers Squibb
Chief Commercial Officer, Ensysce Biosciences
Vice President, Pipeline Commercialization Strategy, AbbVie
Vice President Marketing & Launch Excellence, Bristol Myers Squibb
Vice President of Commercial Operations , Shionogi
Senior Director, Global Oncology New Products Planning, Sanofi
Head of Patient Access, Brand Strategy & Operations - PDT, Patient and Market Access, Takeda Pharmaceuticals
Head of Marketing and New Product Planning, Orca Bio
Executive Director, Global Marketing & New Product Planning, Unicycive Therapeutics
Head of Launch and Business Excellence, Takeda
Director, Global Oncology Market Access and Pricing, New Products/Alliances, Merck
Product Development & Product Launch, Senior GPM, Roche
Vice President, US Neuroscience Marketing, Franchise & Key Account Management, Johnson & Johnson
Chief Commercial Officer, Tarsus Pharmaceuticals
PharmD, Chief Strategy Officer and Head of Commercial, Bicycle Therapeutics
MD, MBA, Senior Director, DS&AI Products: Commercial and Medical Affairs, Commercial Digital Health, AstraZeneca
PhD, MBA, Executive Director, Global Product Strategy & Head of New Product Commercialization, BioMarin Pharmaceutical Inc.
Global Franchise Head of IO & GI Cancer, AstraZeneca
Global Head of Patient Centricity, Astellas
Senior Vice President, Chief Commercial Officer Specialty Pharma, Amneal Pharma
Executive Vice President & Partner, Precision AQ
Global Head of Commercial Data Science & AI, Pfizer
Senior Vice President, Head of Bayer US Pharmaceuticals Product and Pipeline, Bayer
Executive Director, Commercial Strategy, SystImmune
Early Value Lead - Mental Health, Boehringer Ingelheim
Senior Director, Global Marketing, Genmab
Chief Business Officer, Immunis Inc
Manager, Daiichi Sankyo Co., Ltd.
Lead Associate, Daiichi Sankyo Co., Ltd.
Oncology Lead, New Product Planning, Jazz Pharmaceuticals
Sr. Director - Commercial Strategy & Business Dev, Jubilant Radioharmaceuticals
Senior Dir, Digital and Web Enablement, CSL Behring
Director, Strategic Planning, Merck
Director Business Innovation, Merck
Director, Commercial Strategy & Planning, Exelixis
Vice President II, Commercial Strategy & Planning, Exelixis
Head of Asset Evaluation & Strategy, LES LABORATOIRES SERVIER
Sr Director, Global Business Strategy & Analytics, Daiichi Sankyo
Exec Dir, Global Product Strategy, Passage Bio
Director, Commercial Data Science & AI, Oncology, AstraZeneca
Digital Strategic Delivery Manager, AstraZeneca
Global Commercial Operations - Senior Manager, AstraZeneca
Global Value Lead, Boehringer Ingelheim Pharmaceuticals
Patient services, Boehringer Ingelheim
2025 Featured Commercialization Sessions
2025 Featured Commercialization Speakers
Key topics covered in the Commercialization track:
Pipeline Prioritization, Maximizing Commercial Impact
IRA Impacts on Drug Pricing, Access Strategies
Market Intelligence for Accurate Forecasting
R&D, Clinical, and Commercial team Collaboration for Successful Launches
Brand Messaging, Adapting to Market Demands
Your pass unlocks every community—Marketing, PR, Medical Affairs & Commercialization.
Where Pharma's Boldest Minds Define the Future of Commercialization
Experience the pulse of pharma innovation at Fierce Pharma Week’s Commercialization community, where groundbreaking strategies meet game-changing connections. Be at the epicenter as industry titans shape the future of drug commercialization.
Let's work together!
Find out why Fierce Pharma Week is the ultimate networking opportunity to reach key decision makers across every corner of the biopharma ecosystem.